Organic & Biomolecular Chemistry
Paper
NMR (400 MHz, CDCl3) δ (ppm): 8.02 (d, J = 16.0 Hz, 1H), 7.76 (ppm): 168.7, 166.8, 134.6, 133.3, 133.1, 132.2, 130.1, 128.6,
(d, J = 7.6 Hz, 2H), 7.63 (t, J = 7.6 Hz, 1H), 7.51 (t, J = 7.8 Hz, 126.7, 116.4, 115.9, 111.9, 70.7, 69.8, 69.3, 66.7, 63.6, 15.1.
2H), 7.02 (d, J = 2.0 Hz, 1H), 6.84 (d, J = 3.2 Hz, 1H), 6.28–6.24 HRMS (ESI) m/z: calcd for C20H23NNaO5 [M + Na]+: 380.1468,
(m, 2H), 1.89–1.86 (m, 2H), 1.75–1.72 (m, 2H), 1.56–1.23 (m, found 380.1491.
7H). 13C NMR (100 MHz, CDCl3) δ (ppm): 168.8, 166.3, 133.8,
2-Methoxyethyl (E)-3-(1-benzoyl-1H-pyrrol-2-yl)acrylate (3ai).
133.4, 133.1, 132.3, 130.1, 128.6, 126.5, 117.5, 115.6, 111.9, Synthesis was carried out according to the general procedure,
72.5, 31.7, 25.5, 23.8. HRMS (ESI) m/z: calcd for C20H21NNaO3 and compound 3ai was obtained in 73% yield as a pale yellow
[M + Na]+: 346.1414, found 346.1409.
solid after purification by silica gel column chromatography.
1
(1S,4S)-1,7,7-Trimethylbicyclo[2.2.1]heptan-2-yl(E)-3-(1-benzoyl- Mp: 95–96 °C. H NMR (400 MHz, CDCl3) δ (ppm): 8.09 (d, J =
1H-pyrrol-2-yl)acrylate (3ae). Synthesis was carried out accord- 16.0 Hz, 1H), 7.76 (d, J = 7.2 Hz, 2H), 7.64 (t, J = 7.4 Hz, 1H),
ing to the general procedure, and compound 3ae was obtained 7.51 (t, J = 7.6 Hz, 2H), 7.03–7.01 (m, 1H), 6.85 (d, J = 3.2 Hz,
in 51% yield as a colorless oil after purification by silica gel 1H), 6.32 (d, J = 16.0 Hz, 1H), 6.28 (t, J = 3.4 Hz, 1H), 4.33 (t, J =
1
column chromatography. H NMR (400 MHz, CDCl3) δ (ppm): 4.8 Hz, 2H), 3.65 (t, J = 4.6 Hz, 2H), 3.41 (s, 3H). 13C NMR
8.03 (d, J = 16.0 Hz, 1H), 7.76 (d, J = 7.2 Hz, 2H), 7.63 (t, J = (100 MHz, CDCl3) δ (ppm): 168.7, 166.9, 134.7, 133.3, 133.1,
7.4 Hz, 1H), 7.51 (t, J = 7.8 Hz, 2H), 7.03–7.02 (m, 1H), 6.85 (d, 132.1, 130.1, 128.6, 126.7, 116.3, 115.9, 111.9, 70.6, 63.4, 59.0.
J = 3.2 Hz, 1H), 6.28–6.22 (m, 2H), 4.78–4.75 (m, 1H), 1.87–1.77 HRMS (ESI) m/z: calcd for C17H17NNaO4 [M + Na]+: 322.1050,
(m, 2H), 1.74–1.71 (m, 1H), 1.60–1.52 (m, 2H), 1.25–1.21 (m, found 322.1054.
2H), 1.03 (s, 3H), 0.87 (s, 3H), 0.84 (s, 3H). 13C NMR (100 MHz,
2-Phenoxyethyl (E)-3-(1-benzoyl-1H-pyrrol-2-yl)acrylate (3aj).
CDCl3) δ (ppm): 168.7, 166.4, 133.8, 133.5, 133.0, 132.2, 130.0, Synthesis was carried out according to the general procedure,
128.6, 126.6, 117.5, 115.6, 111.9, 80.9, 48.9, 47.0, 45.1, 38.8, and compound 3aj was obtained in 82% yield as a colorless oil
33.7, 27.1, 20.1, 20.0, 11.5. HRMS (ESI) m/z: calcd for after purification by silica gel column chromatography. 1H
C23H25NNaO3 [M + Na]+: 386.1727, found 386.1731.
Phenyl (E)-3-(1-benzoyl-1H-pyrrol-2-yl)acrylate
NMR (400 MHz, CDCl3) δ (ppm): 8.10 (d, J = 16.0 Hz, 1H), 7.76
(3af). (d, J = 7.2 Hz, 2H), 7.63 (t, J = 7.4 Hz, 1H), 7.51 (t, J = 7.8 Hz,
Synthesis was carried out according to the general procedure, 2H), 7.28 (t, J = 8.0 Hz, 2H), 7.04–7.03 (m, 1H), 6.97–6.93 (m,
and compound 3af was obtained in 69% yield as a colorless oil 3H), 6.86 (d, J = 3.2 Hz, 1H), 6.32 (d, J = 16.0 Hz, 1H), 6.28 (t,
1
after purification by silica gel column chromatography. H NMR J = 3.4 Hz, 1H), 4.53 (t, J = 5.0 Hz, 2H), 4.22 (t, J = 4.8 Hz, 2H).
(400 MHz, CDCl3) δ (ppm): 8.29 (d, J = 16.0 Hz, 1H), 7.78 (d, J = 13C NMR (100 MHz, CDCl3) δ (ppm): 168.6, 166.8, 158.7, 134.9,
6.8 Hz, 2H), 7.65 (t, J = 7.6 Hz, 1H), 7.53 (t, J = 7.6 Hz, 2H), 7.39 133.2, 133.1, 132.1, 130.1, 129.5, 128.6, 126.7, 121.1, 116.0,
(t, J = 7.8 Hz, 2H), 7.23 (t, J = 7.4 Hz, 1H), 7.15 (d, J = 7.6 Hz, 2H), 114.6, 111.9, 65.9, 62.7. HRMS (ESI) m/z: calcd for
7.09–7.07 (m, 1H), 6.97 (d, J = 3.2 Hz, 1H), 6.46 (d, J = 16.0 Hz, C22H19NNaO4 [M + Na]+: 384.1206, found 384.1201.
1H), 6.33 (t, J = 3.4 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ (ppm):
(Tetrahydrofuran-2-yl)methyl (E)-3-(1-benzoyl-1H-pyrrol-2-yl)
168.7, 165.3, 150.8, 135.9, 133.2, 133.1, 131.9, 130.1, 129.3, 128.7, acrylate (3ak). Synthesis was carried out according to the
127.1, 125.6, 121.7, 116.5, 115.6, 112.1. HRMS (ESI) m/z: calcd for general procedure, and compound 3ak was obtained in 80%
C20H15NNaO3 [M + Na]+: 340.0944, found 340.0941.
Benzyl (E)-3-(1-benzoyl-1H-pyrrol-2-yl)acrylate
yield as a colorless oil after purification by silica gel column
(3ag). chromatography. H NMR (400 MHz, CDCl3) δ (ppm): 8.09 (d,
1
Synthesis was carried out according to the general procedure, J = 16.0 Hz, 1H), 7.75 (d, J = 7.2 Hz, 2H), 7.63 (t, J = 7.4 Hz,
and compound 3ag was obtained in 66% yield as a colorless 1H), 7.50 (t, J = 7.4 Hz, 2H), 7.02–7.01 (m, 1H), 6.85 (d, J = 3.6
1
oil after purification by silica gel column chromatography. H Hz, 1H), 6.32 (d, J = 16.0 Hz, 1H), 6.27 (t, J = 3.4 Hz, 1H),
NMR (400 MHz, CDCl3) δ (ppm): 8.11 (d, J = 16.0 Hz, 1H), 7.76 4.26–4.23 (m, 1H), 4.20–4.08 (m, 2H), 3.93–3.88 (m, 1H),
(d, J = 6.8 Hz, 2H), 7.63 (t, J = 7.6 Hz, 1H), 7.51 (t, J = 7.8 Hz, 3.82–3.78 (m, 1H), 2.06–1.86 (m, 3H), 1.69–1.60 (m, 1H). 13C
2H), 7.38–7.33 (m, 5H), 7.04–7.03 (m, 1H), 6.86 (d, J = 3.2 Hz, NMR (100 MHz, CDCl3) δ (ppm): 168.6, 166.8, 134.6, 133.3,
1H), 6.32 (d, J = 16.0 Hz, 1H), 6.28 (t, J = 3.4 Hz, 1H), 5.22 (s, 133.1, 132.1, 130.0, 128.6, 126.7, 116.3, 115.8, 111.9, 76.6, 68.4,
2H). 13C NMR (100 MHz, CDCl3) δ (ppm): 168.7, 166.7, 136.2, 66.4, 28.0, 25.6. HRMS (ESI) m/z: calcd for C19H19NNaO4 [M +
134.7, 133.3, 133.1, 132.1, 130.1, 128.6, 128.5, 128.2, 128.1, Na]+: 348.1206, found 348.1210.
126.7, 116.3, 115.9, 111.9, 66.1. HRMS (ESI) m/z: calcd for
2,5-Dioxopyrrolidin-1-yl (E)-3-(1-benzoyl-1H-pyrrol-2-yl)acry-
late (3al). Synthesis was carried out according to the general
C21H17NNaO3 [M + Na]+: 354.1101, found 354.1106.
2-(2-Ethoxyethoxy)ethyl (E)-3-(1-benzoyl-1H-pyrrol-2-yl)acry- procedure, and compound 3al was obtained in 54% yield as a
late (3ah). Synthesis was carried out according to the general colorless oil after purification by silica gel column chromato-
1
procedure, and compound 3ah was obtained in 61% yield as a graphy. H NMR (400 MHz, CDCl3) δ (ppm): 8.36 (d, J = 16.0
colorless oil after purification by silica gel column chromato- Hz, 1H), 7.76 (d, J = 6.8 Hz, 2H), 7.65 (t, J = 7.4 Hz, 1H), 7.53 (t,
1
graphy. H NMR (400 MHz, CDCl3) δ (ppm): 8.09 (d, J = 16.0 J = 7.8 Hz, 2H), 7.11–7.10 (m, 1H), 7.02 (d, J = 3.6 Hz, 1H), 6.41
Hz, 1H), 7.76 (d, J = 6.8 Hz, 2H), 7.64 (t, J = 7.4 Hz, 1H), 7.51 (t, (d, J = 16.0 Hz, 1H), 6.33 (t, J = 3.4 Hz, 1H), 2.86 (s, 4H). 13C
J = 7.8 Hz, 2H), 7.03–7.02 (m, 1H), 6.85 (d, J = 3.2 Hz, 1H), NMR (100 MHz, CDCl3) δ (ppm): 169.4, 168.5, 162.0, 139.1,
6.33–6.27 (m, 2H), 4.34 (t, J = 5.0 Hz, 2H), 3.76 (t, J = 4.8 Hz, 133.3, 133.0, 131.4, 130.1, 128.7, 128.1, 117.8, 112.3, 109.2,
2H), 3.69–3.67 (m, 2H), 3.61–3.59 (m, 2H), 3.53 (q, J = 7.2 Hz, 25.6. HRMS (ESI) m/z: calcd for C18H14N2NaO5 [M + Na]+:
2H), 1.20 (t, J = 7.0 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 361.0795, found 361.0800.
This journal is © The Royal Society of Chemistry 2019
Org. Biomol. Chem.